Promotive action of 2-acetylaminofluorene on hepatic precancerous lesions initiated by diethylnitrosamine in rats: Molecular study

doi:10.4254/wjh.v13.i3.328

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 13, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5651)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-3) series.

Item

Count

PDF

312

WORD

226

HTML

2688

Figures (1-5)

435

Tables (1-3)

393

Sum=4054

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

556

Download

1041

Sum=1597

Mar 27, 2021 (publication date) through Nov 26, 2024

Times Cited of This Article

Times Cited (5)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Mar 27, 2021; 13(3): 328-342
Published online Mar 27, 2021. doi: 10.4254/wjh.v13.i3.328

Table 1 Expression rate of hepatocytes positive for proliferating cell nuclear antigen was calculated as number of positive field expression in 10 fields per rat liver tissue

Group	10 wk duration	16 wk duration
DEN	+	++
DEN + 100 AAF	+	++
DEN + 200 AAF	++	+++
DEN + 300 AAF	++	+++

+: Positive expression found in 1-3 fields; ++: Positive expression found in 4-6 fields; +++: Positive expression found in 7-10 field. DEN: Diethylnitrosamine; AAF: Acetylaminofluorene.

Table 2 Effect of diethylnitrosamine and 2-acetylaminofluorene on alpha-fetoprotein and liver function

	AFP	ALT	Total bilirubin	Direct bilirubin	Albumin
Naïve	22.8 ± 1.13	33.3 ± 6.83	0.30 ± 0.18	0.27 ± 0.14	3.77 ± 0.23
Week 10
DEN	89.2 ± 28.8^d	63.0 ± 27.5^d	1.44 ± 0.45^d	1.03 ± 0.14^d	2.49 ± 0.15^d
DEN + 100 AAF	116 ± 52.1^d	78.3 ± 17.8^d	2.07 ± 0.44^d^,^e	1.40 ± 0.39^d	2.83 ± 0.19^d
DEN + 200 AAF	223 ± 124^b^,^d	82.7 ± 12.7^d	2.73 ± 0.23^a^,^d^,^e	1.67 ± 0.19^a^,^d^,^e	2.73 ± 0.14^d
DEN + 300 AAF	305 ± 126^d^,^e	98.0 ± 10.7^d^,^e	3.13 ± 0.36^b^,^d^,^e	2.13 ± 0.61^d^,^e	3.15 ± 0.38^c^,^d^,^e
Week 16
DEN	159 ± 32.2^d	94.1 ± 6.4^d	2.13 ± 0.55^d	1.60 ± 0.39^d	2.0 ± 0.62^d
DEN + 100 AAF	290 ± 241^d	104 ± 31.9^d	2.23 ± 0.36^d	2.25 ± 0.63^d	2.57 ± 0.37^d
DEN + 200 AAF	815 ± 143^a^,^d^,^f	128 ± 36.9^d	4.10 ± 0.39^a^,^d^,^f	2.53 ± 0.63^a^,^d^,^f	2.17 ± 0.29^d
DEN + 300 AAF	1059 ± 360^b^,^d^,^f	210 ± 63.2^b^,^c^,^d^,^f	4.47 ± 0.99^b^,^d^,^f	3.10 ± 0.39^d^,^f	2.13 ± 0.67^b^,^c^,^d^,^f

Values are mean ± SD; number of animals = 6 rats/each group.

^aP < 0.05 when DEN + 200 acetylaminofluorene (AAF) is compared to the DEN + 100 AAF.

^bP < 0.05 when DEN + 300 AAF is compared to the DEN + 100 AAF.

^cP < 0.05 when DEN + 300 AAF is compared to the DEN + 200 AAF.

^dP < 0.05 compared to the naïve group.

^eP < 0.05 compared to the diethylnitrosamine (DEN) group at week 10 group.

^fP < 0.05 compared to the DEN at week 16 group. One-way ANOVA followed by Tukey's multiple comparison test. DEN: Diethylnitrosamine; 2-AAF: 2-Acetylaminofluorene; AFP: Alpha-fetoprotein; ALT: Alanine aminotransferase.

Table 3 Effect of diethylnitrosamine and 2-acetylaminofluorene on relative quantification of lncRNA-RP11-513I15.6 (long-noncoding RNA), relative quantification of miR-1262 and relative quantification of miR-1298 (microRNA)

	RQ of lncRNA-RP11-513I15.6		RQ of miR-1262		RQ of miR-1298
	Liver	Serum	Liver	Serum	Liver	Serum
Naïve	2.33 ± 0.31	1.86 ± 0.41	0.38 ± 0.09	0.26 ± 0.34	0.77 ± 0.26	0.1 ± 0.04
Week 10
DEN	1.31 ± 0.36^d	0.99 ± 0.15^d	1.63 ± 0.28^d	1.40 ± 0.13^d	1.55 ± 0.37^d	1.08 ± 0.11^d
DEN + 100 AAF	1.03 ± 0.2^d	0.63 ± 0.13^d^,^e	2.26 ± 0.54^d	2.23 ± 0.19^d	1.85 ± 0.12^d	1.48 ± 0.56^d
DEN + 200 AAF	0.58 ± 0.12^a^,^d^,^e	0.44 ± 0.05^d^,^e	2.52 ± 0.44^d^,^e	2.81 ± 0.49^d^,^e	2.46 ± 0.37^d^,^e	1.82 ± 0.47^b^,^c^,^d^,^e
DEN + 300 AAF	0.47 ± 0.037^b^,^d^,^e	0.39 ± 0.005^d^,^e	3.9 ± 0.36^d^,^e	3.59 ± 1.10^b^,^d^,^e	2.88 ± 0.11^d^,^e	3.30 ± 0.18^d^,^e
Week 16
DEN	0.76 ± 0.1^d	0.52 ± 0.13^d	3.12 ± 0.62^d	2.15 ± 0.08^d	2.52 ± 0.56^d	2.23 ± 0.26^d
DEN + 100 AAF	0.46 ± 0.04^d^,^f	0.22 ± 0.04^d	4.48 ± 0.63^d^,^f	4.08 ± 0.32^d	3.92 ± 0.61^d^,^f	4.56 ± 0.61^d^,^f
DEN + 200 AAF	0.26 ± 0.07^d^,^f	0.14 ± 0.07^d^,^f	5.71 ± 0.76^a^,^d^,^f	7.38 ± 2.24^d^,^f	4.58 ± 0.56^d^,^f	5.78 ± 1.72^d^,^f
DEN + 300 AAF	0.14 ± 0.04^b^,^d^,^f	0.12 ± 0.06^d^,^f	6.45 ± 1.04^b^,^d^,^f	9.78 ± 4.32^b^,^d^,^f	5.89 ± 1.27^d^,^f	7.38 ± 2.05^b^,^d^,^f